Standout Papers
Citation Impact
Citing Papers
A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication
2017 StandoutNobel
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Valuation of health states in the US study to establish disability weights: lessons from the literature
2010
Substance Use Disorders in a Primary Care Sample Receiving Daily Opioid Therapy
2007
Measuring the Global Burden of Disease
2013 Standout
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
The Impact of Age-Related Macular Degeneration on Health Status Utility Values
2005
Valuing health-related quality of life: An EQ-5D-5L value set for England
2017
Variation in Chinese population health related quality of life: Results from a EuroQol study in Beijing, China
2005
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
The Well-Being and Personal Wellness Promotion Strategies of Medical Oncologists in the North Central Cancer Treatment Group
2005
The estimation of a preference-based measure of health from the SF-36
2002 Standout
Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.
1998
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
2011 Standout
Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes
2004
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2014 Standout
Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
2001
Ulcerative Colitis
2011 Standout
A Non-randomised Controlled Trial of the Clinical and Cost Effectiveness of a Supervised Exercise Programme for Claudication
2006
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)
2005
Evaluating Equivalency Between Response Systems
2007
Improvement of quality of life in hospitalized depressed elderly
2010
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
2012
A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial
2007
A National Catalog of Preference-Based Scores for Chronic Conditions in the United States
2005
The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies
2001
Vitamin D Deficiency
2007 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
2009 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis
2009
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Towards environmentally sustainable human behaviour: targeting non-conscious and conscious processes for effective and acceptable policies
2017
Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
2008
EQ-SD: a measure of health status from the EuroQol Group
2001 Standout
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
2000
Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry
2007
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Comparison of Finnish and U.S.-based Visual Analog Scale Valuations of the EQ-5D Measure
2000
EuroQol: the current state of play
1996 Standout
Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
2018 StandoutNobel
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
2005
Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D
1999
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Principles for allocation of scarce medical interventions
2009
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D 3 ) for prevention of fractures in primary care
2005
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
2006 Standout
Deriving a Preference-Based Single Index from the UK SF-36 Health Survey
1998
The Future of Memory: Remembering, Imagining, and the Brain
2012 StandoutNobel
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
2005 Standout
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Quality of Life and Affective Well-Being in Middle-Aged and Older People with Chronic Medical Illnesses: A Cross-Sectional Population Based Study
2011
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
2008
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Association of Perceived Medical Errors With Resident Distress and Empathy
2006 Standout
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Rheumatoid arthritis
2010 Standout
Gastric cancer
2020 Standout
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
2009 Standout
A Comparison of Affect Ratings Obtained with Ecological Momentary Assessment and the Day Reconstruction Method
2010 Nobel
Do People Value Their Own Future Health Differently from Others' Future Health?
1999
Population-based Time Preferences for Future Health Outcomes
2000
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
2007 Standout
Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)
1997
Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
2014 Standout
Comparison of the EQ-5D and SF-12 Health Surveys in a General Population Survey in Alberta, Canada
2000
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Constant and decreasing timing aversion for saving lives
1997
Five preference-based indexes in cataract and heart failure patients were not equally responsive to change
2010
A cost-effectiveness analysis of stays in intensive care units
2001
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment
2010
The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Prospection: Experiencing the Future
2007 Science
Individual time preferences for own health: an application of a dichotomous choice question with follow-up
1999
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
The Social Costs of Alcohol in Sweden 2002
2006
Metabolic reprogramming by HIF-1 promotes the survival of bone marrow–derived angiogenic cells in ischemic tissue
2011 StandoutNobel
Evaluative and hedonic wellbeing among those with and without children at home
2014 StandoutNobel
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
A review of the use of health status measures in economic evaluation.
1999
In Defense of Parenthood
2012
Does the stork deliver happiness? Parenthood and life satisfaction
2016
Iron-Deficiency Anemia
2015 Standout
Meat consumption, health, and the environment
2018 StandoutScience
Impacting Quality of Life for Patients With Advanced Cancer With a Structured Multidisciplinary Intervention: A Randomized Controlled Trial
2006
Developments in the Measurement of Subjective Well-Being
2006 StandoutNobel
Time Discounting and Time Preference: A Critical Review
2002 Standout
Suffer the little children: Measuring the effects of parenthood on well-being worldwide
2011
CAR T cell immunotherapy for human cancer
2018 StandoutScience
A Review of the Use of Health Status Measures in Economic Evaluation
1999
Separate Neural Systems Value Immediate and Delayed Monetary Rewards
2004 StandoutScience
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
2020 Standout
Does the Stork Deliver Happiness? Parenthood and Life Satisfaction
2012
Works of Paul Dolan being referenced
Inconsistency and health state valuations
1996
Principles of justice in health care rationing
2000
Valuing Health-Related Quality of Life
1999
Modelling valuations for health states: the effect of duration
1996
Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values
1997
Variations in population health status: results from a United Kingdom national questionnaire survey
1998
The time trade-off method: Results from a general population study
1996
Valuing health states: A comparison of methods
1996
Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
2002
The role of adaptation to disability and disease in health state valuation: a preliminary normative analysis
2002
Quality of life analysis in patients with lower limb ischaemia: Suggestions for European standardisation
1997
A single European currency for EQ-5D health states
2003
The Cost of Treating Osteoporotic Fractures in the United Kingdom Female Population
1998
Valuing health status using VAS and TTO: What lies behind the numbers?
1997
QALY maximisation and people's preferences: a methodological review of the literature
2004
The effect of experience of illness on health state valuations
1996
“Pay them if it works”: Discrete choice experiments on the acceptability of financial incentives to change health related behaviour
2012
An inquiry into the different perspectives that can be used when eliciting preferences in health
2002
Prescribing by general practitioners after an osteoporotic fracture
1998
Modeling Valuations for EuroQol Health States
1997 Standout
Time preference, duration and health state valuations
1995
Measuring people's preferences regarding ageism in health: some methodological issues and some fresh evidence
2003
Health state valuations from the general public using the Visual Analogue Scale
1996
Estimating the Intangible Victim Costs of Violent Crime
2005
Equity in health: the importance of different health streams
2001
Accounting for the Richness of Daily Activities
2009
Risk–risk versus standard gamble procedures for measuring health state utilities
1995
Interpretations of Utility and Their Implications for the Valuation of Health
2007 Nobel
Preparatory study for the revaluation of the EQ-5D tariff: methodology report
2014
How Can Measures of Subjective Well-Being Be Used to Inform Public Policy?
2007
Do we really know what makes us happy? A review of the economic literature on the factors associated with subjective well-being
2007 Standout
The effect of past and present illness experience on the valuations of health states.
1995